Codelivery of paclitaxel and small interfering RNA by octadecyl quaternized carboxymethyl chitosan-modified cationic liposome for combined cancer therapy
In conclusion, the results indicate that cationic liposome could be further developed as a codelivery system for chemotherapy drugs and therapeutic small interfering RNAs.
Source: Journal of Biomaterials Applications - Category: Materials Science Authors: Zhang, R., Wang, S.-B., Chen, A.-Z., Chen, W.-G., Liu, Y.-G., Wu, W.-G., Kang, Y.-Q., Ye, S.-F. Tags: Nanotechnology in Biomaterials Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Cholesterol | Materials Science | Nanotechnology